Clinical Scorecard: Hypertension, Heart Failure, and Kidney Damage in Subacute Kawasaki Disease: A Case Study and Review of Existing Literature
At a Glance
Category
Detail
Condition
Key Mechanisms
Acute systemic vasculitis affecting vascular endothelium, leading to coronary artery abnormalities, persistent endothelial dysfunction, and cardiovascular consequences.
Target Population
Care Setting
Key Highlights
Kawasaki disease is the leading cause of acquired heart disease in children.
The case presented highlights a triad of hypertension, heart failure, and kidney damage during the subacute phase.
Initial IVIG therapy can resolve inflammation but may not prevent vascular complications.
Persistent endothelial dysfunction is a significant contributor to morbidity in KD.
Monitoring during the subacute phase should include blood pressure and echocardiographic evaluations, as well as ongoing vascular health assessments.
Guideline-Based Recommendations
Diagnosis
Management
Administer intravenous immunoglobulin (IVIG) (2 g/kg) and aspirin (30 mg/kg/day) as per established protocols.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
IVIG (2 g/kg) and aspirin (30 mg/kg/day) were effective in initial treatment, but ongoing monitoring is crucial for vascular health and potential long-term outcomes.
Clinical Best Practices
Implement routine blood pressure assessments in the subacute phase of Kawasaki disease.
Conduct thorough echocardiographic evaluations to monitor cardiac function.
Screen for renal impairment using urinary albumin-to-creatinine ratios.
Establish follow-up frequency and additional tests for renal function.
